1H NMR metabonomic analysis in renal cell carcinoma: A possible diagnostic tool

Journal of Proteome Research

Volumn 9, Issue 8, 2010, Pages 4038-4044

  Zira, Athina N ^a   Theocharis, Stamatios E ^a   Mitropoulos, Dionisios ^a   Migdalis, Vasilios ^a   Mikros, Emmanuel ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Metabonomics; NMR; OSC; PCA; PLS DA; RCC

Indexed keywords

ACETIC ACID; ACETOACETIC ACID; ALANINE; CHOLESTEROL; CHOLINE; GLUCOSE; GLYCOPROTEIN; LACTIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PYRUVIC ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY CARCINOMA; LACTATE BLOOD LEVEL; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MULTIVARIATE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTON NUCLEAR MAGNETIC RESONANCE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; BLOOD CHEMICAL ANALYSIS; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; HUMANS; KIDNEY NEOPLASMS; METABOLOMICS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PRINCIPAL COMPONENT ANALYSIS;

EID: 77955456419     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100226m     Document Type: Article

References (44)

1. Furniss, D.; Harnden, P.; Ali, N.; Royston, P.; Eisen, T.; Oliver, R. T.; Hancock, B. W. On behalf of the National Cancer Research Institute Renal Clinical Studies Group Cancer Treat. Rev. 2008, 34, 407-426
2. Mancini, V.; Battaglia, M.; Ditonno, P.; Palazzo, S.; Lastilla, G.; Montironi, R.; Bettocchi, C.; Cavalcanti, E.; Ranieri, E.; Selvaggi, F. P. Current insights in renal cancer pathology Urol. Oncol.: Semin. Orig. Invest. 2008, 26, 225-238
3. Figlin, R. A. Renal cell carcinoma: management of advanced disease J. Urol. 1999, 161, 381-387
4. Nogueira, M.; Kim, H. L. Molecular markers for predicting prognosis in renal cell carcinoma Urol. Oncol.: Semin. Orig. Invest. 2008, 26, 113-124
5. Crispen, P. L.; Boorjian, S. A.; Loshe, C. M.; Leibovich, B. C.; Kwon, E. D. Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers Cancer 2008, 113, 450-460
6. Nicholson, J. K.; Lindon, J. C.; Holmes, E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 1999, 29, 1181-1189
7. Lindon, J. C.; Holmes, E.; Nicholson, J. K. Toxicological applications of magnetic resonance Prog. Nucl. Magn. Reson. Spectrosc. 2004, 45, 109-143
8. Brindle, J. T.; Antti, H.; Holmes, E.; Tranter, G.; Nicholson, J. K.; Bethell, H. W.; Clarke, S.; Schofield, P. M.; McKilligin, E.; Mosedale, D. E.; Grainger, D. J. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics Nat. Med. 2002, 8, 1439-1444
9. Odunsi, K.; Wollman, R. M.; Ambrosone, C. B.; Hutson, A.; McCann, S. E.; Tammela, J.; Geisler, J. P.; Miller, G.; Sellers, T.; Cliby, W.; Qian, F.; Keitz, B.; Intengan, M.; Lele, S.; Alderfer, J. L. Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics Int. J. Cancer. 2005, 113, 782-8
10. Beckonert, O.; Monnerjahn, J.; Bonk, U.; Leibfritz, D. Visualizing metabolic changes in breast-cancer tissue using 1H-NMR spectroscopy and self-organizing maps NMR Biomed. 2003, 16, 1-11
11. Beger, R. D.; Schnackenberg, L. K.; Holland, R. D.; Li, D.; Dragan, Y. Metabonomic models of human pancreatic cancer using 1D proton NMR spectra of lipids in plasma Metabolomics 2006, 2, 125-134
12. Tiziani, S.; Lopes, V.; Günther, U. L. Early stage diagnosis of oral cancer using 1H NMR-based metabolomics Neoplasia 2009, 11, 269-276
13. Kind, T.; Tolstikov, V.; Fiehn, O.; Weiss, R. H. A comprehensive urinary metabolomic approach for identifying kidney cancer Anal. Biochem. 2007, 363, 185-195
14. Perroud, B.; Lee, J.; Valkova, N.; Dhirapong, A.; Lin, P.-Y.; Fiehn, O.; Kültz, D.; Weiss, R. H. Pathway analysis of kidney cancer using proteomics and metabolic profiling Mol. Cancer 2006, 5:64, 1-17
15. Kim, S. K.; Aronov, P.; Zakharkin, S. O.; Anderson, D.; Perroud, B.; Thompson, I. M.; Weiss, R. H. Urine metabolomics analysis for kidney cancer detection and biomarker discovery Mol. Cell. Proteomics 2009, 8, 558-570
16. Tate, A. R.; Foxall, P. J. D.; Holmes, E.; Moka, D.; Spraul, M.; Nicholson, J. K.; Lindon, J. C. Distinction between normal and renal cell carcinoma kidney cortical biopsy samples using pattern recognition of 1H magic angle spinning (MAS) NMR spectra NMR Biomed. 2000, 13, 64-71
17. Gao, H.; Dong, B.; Liu, X.; Xuan, H.; Huang, Y.; Lin, D. Metabonomic profiling of renal cell carcinoma: high-resolution proton nuclear magnetic resonance spectroscopy of human serum with multivariate data analysis Anal. Chim. Acta 2008, 624, 269-277
18. Sobin, L. H.; Wittekind, C. TNM classifications: kidney. In TNM Classifications of Malignant Tumours, 6th ed.; Wiley: New York, 2003; pp 193 - 195.
19. Fuhrman, S. A.; Lasky, L. C.; Limas, C. Prognostic significance of morphologic parameters in renal cell carcinoma Am. J. Surg. Pathol. 1982, 6, 655-663
20. Barton, R. H.; Waterman, D.; Bonner, F. W.; Holmes, E.; Clarke, R.; the PROCARDIS Consortium
21. Nicholson, J. K.; Lindon, J. C. The influence of EDTA and citrate anticoagulant addition to human plasma on information recovery from NMR-based metabolic profiling studies Mol. BioSyst. 2010, 6, 215-224
22. Lindon, J. C.; Holmes, E.; Nicholson, J. K. Pattern recognition methods and applications in biomedical magnetic resonance Toxicological applications of magnetic resonance Prog. Nucl. Magn. Reson. Spectrosc. 2001, 39, 1-40
23. Wold, S.; Antti, H.; Lindgren, F.; Ohman, I. Orthogonal signal correction of near-infrared spectra Chemom. Intell. Lab. Syst. 1998, 44, 175-185
24. l3C NMR spectroscopy of human blood plasma Anal. Chem. 1995, 67, 793-811
25. Han, W. K.; Alinani, A.; Wu, C. L.; Michaelson, D.; Loda, M.; McGovern, F. J.; Thadhani, R.; Bonventre, J. V. Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma J. Am. Soc, Nephrol 2005, 16, 1126-1134
26. Rogers, M. A.; Clarke, P.; Noble, J.; Munro, N. P.; Paul, A.; Selby, P. J.; Banks, R. E. Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neuralnetwork analysis: identification of key issues affecting potential clinical utility Cancer Res. 2003, 63, 6971-6983
27. Saude, E. J.; Adamko, D.; Rowe, B. H.; Marrie, T.; Sykes, B. D. Variation of metabolites in normal human urine Metabolomics 2007, 3, 439-451
28. Assfalg, M.; Bertini, I.; Colangiuli, D.; Luchinat, C.; Schaefer, H.; Schutz, B.; Spraul, M. Evidence of different metabolic phenotypes in humans Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 1420-1424
29. Whitehead, T. L.; Kieber-Emmons, T. Applying in vitro NMR spectroscopy and 1H NMR metabonomics to breast cancer characterization and detection Prog. Nucl. Magn. Reson. Spectrosc. 2005, 47, 165-174
30. Griffin, J. L.; Kauppinen, R. A. A metabolomics perspective of human brain tumours FEBS J. 2007, 274, 1132-1139
31. Sitter, B.; Lundgren, S.; Bathen, T. F.; Halgunset, J.; Fjosne, H. E.; Gribbestad, I. S. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters NMR Biomed. 2006, 19, 30-40
32. Lindon, J. C.; Nicholson, J. K.; Holmes, E.; Everett, J. R. Metabonomics: metabolic processes studied by NMR spectroscopy of biofluids Concepts Magn. Reson. 2000, 12, 289-320
33. Fuhrman, B.; Wolfovitz, E.; Cogan, U.; Brook, G. J. Hypocholesterolemia and cancer: tumor cells induce enhanced LDL uptake by non-tumor cells and stimulate oxidative modification of LDL Pathophysiology 1999, 6, 205-210
34. Vitols, S.; Angelin, B.; Ericsson, S.; Gahrton, G.; Juliusson, G.; Masquelier, M.; Paul, C.; Peterson, C.; Rudling, M.; Soderberg-Reid, K.; Tidefelt, U. Uptake of low density lipoproteins by human leukemic cells in vivo: Relation to plasma lipoprotein levels and possible relevance formselective chemotherapy Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 2598-2602
35. Fiorenza, A. M.; Branchi, A.; Sommariva, D. Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects Int. J. Clin. Lab. Res. 2000, 30, 141-145
36. Gebhard, R. L.; Clayman, R. V.; Prigge, W. F.; Figenshau, R.; Staley, N. A.; Reesey, C.; Beart, A. Abnormal cholesterol metabolism in renal clear cell carcinoma J. Lipid Res. 1987, 28, 1177-1184 (Pubitemid 17151580)
37. White, R. M. On the occurrence of crystals in tumours J. Pathol. Bacteriol. 1909, 13, 3-10
38. Rudling, M.; Collins, V. P. Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels are coordinately reduced in human renal cell carcinoma Biochim. Biophys. Acta 1996, 1299, 75-79
39. Tosia, M. R.; Tugnoli, V. Cholesteryl esters in malignancy Clin. Chim. Acta 2005, 359, 27-45
40. Abiaka, C.; Al-Awadi, F.; Al-Sayer, H.; Gulshan, S.; Behbehani, A.; Farghally, M.; Simbeye, A. Serum antioxidant and cholesterol levels in patients with different types of cancer J. Clin. Lab. Anal. 2001, 15, 324-330 (Pubitemid 33097027)
41. Süllentrop, F.; Moka, D.; Neunauer, S.; Haupt, G.; Engelmann, U.; Hahn, J.; Schicha, H. 31P NMR spectroscopy of blood plasma: determination and quantification of phospholipid classes in patients with renal cell carcinoma NMR Biomed. 2002, 15, 60-68
42. Kubota, A.; Meguid, M. M.; Hitch, D. C. Amino-acid profiles correlate diagnostically with organ site in 3 kinds of malignant-tumors Cancer 1992, 69, 2343-2348
43. Lai, H. S.; Lee, J. C.; Lee, P. H.; Wang, S. T.; Chen, W. J. Plasma free amino acid profile in cancer patients Semin. Cancer Biol. 2005, 15, 267-276
44. Holmes, E.; Leng, L. R.; Stamler, J.; Bictash, M.; Yap, I. K. S.; Chan, Q.; Ebbels, T.; De Iorio, M.; Brown, I. J.; Veselkov, K. A.; Daviglus, M. L.; Kesteloot, H.; Ueshima, H.; Zhao, L.; Nicholson, J. K.; Elliott, P. Human metabolic phenotype diversity and its association with diet and blood pressure Nature 2008, 453, 396-400